Showing results (21-30 of 59) with videos related to
Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Phase I trial of high-dose mitoxantrone plus cyclophosphamide and filgrastim in patients with advanced breast carcinomaJ A Sparano, N Robert, P Silverman, et al.Blood|May 15, 1993
Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus- and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: a highly active regimenJ A Sparano, P H Wiernik, M Strack, et al.Medical Oncology (Northwood, London, England)|June 27, 1998
Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphomaJ A Sparano, P H Wiernik, X Hu, et al.Medical Oncology (Northwood, London, England)|January 1, 1994
Adjuvant radiotherapy for breast cancer as a risk factor for the development of lung cancerP H Wiernik, N T Sklarin, J P Dutcher, et al.Clinical Breast Cancer|March 20, 2002
Microvessel density and p53 overexpression in young women with breast cancer: a case-control studyB Kalfon, S Fineberg, Y Gu, et al.Bone Marrow Transplantation|January 1, 1995
Pilot study of high-dose mitoxantrone and busulfan plus autologous bone transplantation in patients with advanced malignanciesA Khalil, N Ciobanu, J A Sparano, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 3, 1999
Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical centerJ A Sparano, K Anand, J Desai, et al.Cancer Research|August 1, 1993
Phase I trial of cyclophosphamide, doxorubicin, and 5-fluorouracil plus interferon-alpha 2b in patients with advanced breast cancerJ A Sparano, S Wadler, L Liebes, et al.NPJ Breast Cancer|December 14, 2023
Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancerM Chadha, J White, S M Swain, et al.Transfusion|March 1, 1992
Experience with autologous bone marrow harvesting and transfusion of marrow-derived red cellsN Ciobanu, V Weinberg, J A Sparano, et al.Pageof 6